Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Point-of-care molecular diagnostic devices: an overview.

Pharmacogenomics - 1 Jan 2015

Vu Chi Lan Nguyen, Chan Jianxiong, Todaro Marian, Skafidas Stan, Kwan Patrick

Abstract excerpt

Point-of-care molecular diagnostic devices are a rapidly expanding market. A variety of technologies are being developed for DNA detection and amplification, mostly aiming to detect pathogens. Of the two devices for detection of human genetic variations, both focus on CYP2C19 and have obtained re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2C19
Share to DNA
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Pathology, Molecular

Share to Point-of-Care Systems

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 26229012
DOI: 10.2217/pgs.15.92

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26229012-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Point-of-care molecular diagnostic devices: an overview.PMID 26229012Read ↗

Development of a New Portable Genetic Analyzer for Point-of-Care Molecular Genetics and Pharmacogenomics Analysis.Semantic proximity Read ↗

Medical devices; clinical chemistry and clinical toxicology devices; drug metabolizing enzyme genotyping system. Final rule.Semantic proximity Read ↗

Fast, sensitive point of care electrochemical molecular system for point mutation and select agent detection.Semantic proximity Read ↗

The future of direct-to-consumer clinical genetic testsSemantic proximity Read ↗

Direct-to-consumer genetic testing kits. You send in a sample and get your results online. But is it worth the price?Semantic proximity Read ↗

An Extraction-Free Method for Rapid Detection of CYP2C19 * 2/3/17 Polymorphisms in One Tube using Melting Curve AnalysisSemantic proximity Read ↗

Personalized clinical laboratory diagnostics.Semantic proximity Read ↗

Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review.Semantic proximity Read ↗

Development and Validation of a Rapid Point-of-Care CYP2C19 Genotyping PlatformSemantic proximity Read ↗

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an exampleSemantic proximity Read ↗

Validation of genotyping protocols for diagnostic use.Semantic proximity Read ↗

Clinical utility gene card for: Aniridia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.